A new aggressive surgery approach by the UCD Gynecological Oncology Group has helped improve the survival rates for women with ovarian cancer in Ireland.
Feb 11, 2021
0
3
A study led by researchers at the University of Minnesota Medical School found a way to detect the presence of ovarian cancer in patients using Pap test samples, normally used to detect cervical cancer. Currently, no early ...
Feb 9, 2021
0
2
The prognosis of ovarian cancer is poor, with an estimated five-year survival of only 40% for advanced disease, the stage at which most ovarian carcinomas are diagnosed. These poor outcomes are partly due to the lack of effective ...
Feb 3, 2021
0
42
Scientists at Northwestern Medicine have developed a novel therapy to trick cancer cells into gobbling up what they think is their favorite food—cholesterol—which actually triggers their destruction. What appears to them ...
Jan 26, 2021
0
963
A new targeted treatment has been recommended by the National Institute of Health and Care Excellence (NICE) for some adults with advanced high-grade epithelial ovarian, fallopian tube or primary peritoneal cancer
Jan 20, 2021
0
8
The new, Oxford-developed method for subtyping ovarian cancer has been validated in a recent collaboration between the University of Oxford and Imperial College London. Dubbed the "Oxford Classic," researchers have demonstrated ...
Jan 14, 2021
0
13
A detailed description of how ovarian cancer cells adapt to survive and proliferate in the peritoneal cavity has been published in Frontiers in Oncology. Researchers show that structures inside the cells change as the disease ...
Jan 13, 2021
0
25
A comprehensive study from Uppsala University involving more than 250,000 women shows that oral contraceptive use protects against ovarian and endometrial cancer. The protective effect remains for several decades after discontinuing ...
Dec 17, 2020
0
189
A new paper in JNCI: Journal of the National Cancer Institute, published by Oxford University Press, indicates that receiving assisted reproductive technology does not increase the risk women have for developing ovarian cancer.
Nov 18, 2020
0
17
Population-wide screening for genetic variants linked to hereditary breast and ovarian cancer may be cost effective in women between the ages of 20 and 35, according to a study published in JAMA Network Open.
Nov 16, 2020
0
5
